
Bharat Biotech opens $75m CGT facility in India
With an investment of $75 million, the facility will focus on advanced viral vector production, designed to produce high-titer viral vectors including adeno-associated viruses (AAVs), lentivirus, and adenovirus, essential for CGT production. Bharat …